Literature DB >> 15196060

Effects of organ preservation, ischemia time and caspase inhibition on apoptosis and microcirculation in rat pancreas transplantation.

Oliver Drognitz1, Robert Obermaier, Xuemei Liu, Hannes Neeff, Ernst von Dobschuetz, Ulrich T Hopt, Stefan Benz.   

Abstract

This study was undertaken to examine the impact of ischemia-reperfusion (I/R) injury on microcirculation and apoptosis in experimental pancreas transplantation. Pancreatic grafts were subjected to different preservation solutions and cold ischemia times (CITs): University of Wisconsin (UW), 6-h CITs (group U6); UW, 18-h CITs (group U18); normal saline, 6-h CITs (group S6); and normal saline, 6-h CITs with Z-Asp-2,6-dichlorobenzoyloxymethylketone (pan-caspase inhibitor; group S6 &amp; CI). Nontransplanted animals served as controls. At 1- and 2-h reperfusion microcirculation was assessed by means of intravital microscopy. Apoptosis was detected by in situ nick end-labeling method (TUNEL) at 2-h reperfusion. Deterioration of microcirculation was lowest in group U6 and highest in groups S6 and S6 &amp; CI compared with controls. The apoptotic index (cells per high power fields) of groups U6, U18 and S6 correlated well with functional capillary density (r=- 0,70, p < 0.0001) and leucocyte sticking (r= 0,69, p < 0.0001) at 1-h reperfusion. Caspase inhibition had no impact on microcirculation but significantly reduced AI compared with group S6 (p < 0.001). These data suggest that pancreatic I/R injury-induced apoptotic cell death well predicts the extent of [corrected] microcirculatory impairment. Caspase inhibition might be a promising strategy in reducing I/R injury in pancreas transplantation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196060     DOI: 10.1111/j.1600-6143.2004.00457.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  In Vitro Assessment of Apoptosis and Necrosis Following Cold Storage in a Human Airway Cell Model.

Authors:  William L Corwin; John M Baust; Robert G Vanbuskirk; John G Baust
Journal:  Biopreserv Biobank       Date:  2009-03       Impact factor: 2.300

2.  Donor pretreatment with tetrahydrobiopterin saves pancreatic isografts from ischemia reperfusion injury in a mouse model.

Authors:  M Maglione; R Oberhuber; B Cardini; K Watschinger; M Hermann; P Obrist; P Hengster; W Mark; S Schneeberger; G Werner-Felmayer; J Pratschke; R Margreiter; E R Werner; G Brandacher
Journal:  Am J Transplant       Date:  2010-10       Impact factor: 8.086

3.  Distinctive gene expression profiles characterize donor biopsies from HCV-positive kidney donors.

Authors:  Valeria R Mas; Kellie J Archer; Lacey Suh; Mariano Scian; Marc P Posner; Daniel G Maluf
Journal:  Transplantation       Date:  2010-12-15       Impact factor: 4.939

4.  Neuroprotection of Intermedin Against Cerebral Ischemia/Reperfusion Injury Through Cerebral Microcirculation Improvement and Apoptosis Inhibition.

Authors:  Xin Guo; Jie Yuan; Meixi Li; Meng Wang; Peiyuan Lv
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

5.  Prevention of lethal murine pancreas ischemia reperfusion injury is specific for tetrahydrobiopterin.

Authors:  Manuel Maglione; Benno Cardini; Rupert Oberhuber; Katrin Watschinger; Marcel Jenny; Johanna Gostner; Martin Hermann; Peter Obrist; Raimund Margreiter; Johann Pratschke; Gerald Brandacher; Ernst R Werner
Journal:  Transpl Int       Date:  2012-07-17       Impact factor: 3.782

6.  Donor insulin therapy in intensive care predicts early outcomes after pancreas transplantation.

Authors:  Iestyn M Shapey; Angela Summers; Hussein Khambalia; Petros Yiannoullou; Catherine Fullwood; Neil A Hanley; Titus Augustine; Martin K Rutter; David van Dellen
Journal:  Diabetologia       Date:  2021-03-04       Impact factor: 10.122

7.  Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.

Authors:  Hamad Yadikar; Isabel Torres; Gabrielle Aiello; Milin Kurup; Zhihui Yang; Fan Lin; Firas Kobeissy; Richard Yost; Kevin K Wang
Journal:  PLoS One       Date:  2020-07-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.